You are reading a single comment by @Howard and its replies.
Click here to read the full conversation.
-
I think the bit that was missing here for having a full understanding was that these were the extra doses, not 200 doses which had been purchased and were meant to be provided to specific patients
An anecdote positioned as a story about underperformance actually turns out to be about a missed opportunity to overperform.
It is a shame that nothing better can be done with surplus.
Howard-
An anecdote positioned as a story about underperformance actually turns out to be about a missed opportunity to overperform.
It is a shame that nothing better can be done with surplus.
Agreed. Although based on news reports and other's posts (with more knowledge than me), it sounds like they are in the process of doing something with it, thankfully.
Thanks for the very clear overview! I think the bit that was missing here for having a full understanding was that these were the extra doses, not 200 doses which had been purchased and were meant to be provided to specific patients. Having said that, I agree that it's a bit shit if any of the vaccine is going to waste! I do agree with @Brun, though, that it's a slightly different issue. I also think that @daccordi is probably right that there's a lot more to the regulatory side of things which may make the issue more complex than we (or, at least, I) think.
Hopefully now that it's clear that this is an issue they will have started planning to have the correct syringes on hand.